Ring 1
Ring 2
Ring 3
Ring 4


Financing Rounds

  • Series B
  • Exit
Round Led by Symbiosis
Round Led by Symbiosis

Inspired by the biological function and versatility of platelets, PlateletBio is pioneering the next generation of safer, more effective cell therapies. Its cell therapy platform produces “platelet-like cells” (PLCs) capable of performing vital biological functions and able to be genetically engineered into multiple allogeneic cell therapies. The Company is focused on advancing a diverse pipeline of next-generation cellular therapies for applications in autoimmune diseases, hematology, and inflammation.

plateletbio View Website


  • Cell Therapy


  • Immunology

Development Status

  • Pre-Clinical

Learn More About PlateletBio